Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

Cited In for PubMed (Select 11870207)

1.

Actin and endocytosis in budding yeast.

Goode BL, Eskin JA, Wendland B.

Genetics. 2015 Feb;199(2):315-58. doi: 10.1534/genetics.112.145540.

2.

hsa-mir-30c promotes the invasive phenotype of metastatic breast cancer cells by targeting NOV/CCN3.

Dobson JR, Taipaleenmäki H, Hu YJ, Hong D, van Wijnen AJ, Stein JL, Stein GS, Lian JB, Pratap J.

Cancer Cell Int. 2014 Aug 2;14:73. doi: 10.1186/s12935-014-0073-0. eCollection 2014.

3.

Transcriptome analysis in chicken cecal epithelia upon infection by Eimeria tenella in vivo.

Guo A, Cai J, Gong W, Yan H, Luo X, Tian G, Zhang S, Zhang H, Zhu G, Cai X.

PLoS One. 2013 May 30;8(5):e64236. doi: 10.1371/journal.pone.0064236. Print 2013.

4.

Genome-wide RNAi screening identifies genes inhibiting the migration of glioblastoma cells.

Yang J, Fan J, Li Y, Li F, Chen P, Fan Y, Xia X, Wong ST.

PLoS One. 2013 Apr 12;8(4):e61915. doi: 10.1371/journal.pone.0061915. Print 2013.

5.

MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11.

Bockhorn J, Dalton R, Nwachukwu C, Huang S, Prat A, Yee K, Chang YF, Huo D, Wen Y, Swanson KE, Qiu T, Lu J, Park SY, Dolan ME, Perou CM, Olopade OI, Clarke MF, Greene GL, Liu H.

Nat Commun. 2013;4:1393. doi: 10.1038/ncomms2393.

6.

MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion.

Bockhorn J, Yee K, Chang YF, Prat A, Huo D, Nwachukwu C, Dalton R, Huang S, Swanson KE, Perou CM, Olopade OI, Clarke MF, Greene GL, Liu H.

Breast Cancer Res Treat. 2013 Jan;137(2):373-82. doi: 10.1007/s10549-012-2346-4. Epub 2012 Dec 7.

7.

Cell stiffness is a biomarker of the metastatic potential of ovarian cancer cells.

Xu W, Mezencev R, Kim B, Wang L, McDonald J, Sulchek T.

PLoS One. 2012;7(10):e46609. doi: 10.1371/journal.pone.0046609. Epub 2012 Oct 4.

8.

miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis.

Gaziel-Sovran A, Segura MF, Di Micco R, Collins MK, Hanniford D, Vega-Saenz de Miera E, Rakus JF, Dankert JF, Shang S, Kerbel RS, Bhardwaj N, Shao Y, Darvishian F, Zavadil J, Erlebacher A, Mahal LK, Osman I, Hernando E.

Cancer Cell. 2011 Jul 12;20(1):104-18. doi: 10.1016/j.ccr.2011.05.027.

9.

Minimal requirements for actin filament disassembly revealed by structural analysis of malaria parasite actin-depolymerizing factor 1.

Wong W, Skau CT, Marapana DS, Hanssen E, Taylor NL, Riglar DT, Zuccala ES, Angrisano F, Lewis H, Catimel B, Clarke OB, Kershaw NJ, Perugini MA, Kovar DR, Gulbis JM, Baum J.

Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9869-74. doi: 10.1073/pnas.1018927108. Epub 2011 May 31.

10.

Distinct effects of contraction agonists on the phosphorylation state of cofilin in pulmonary artery smooth muscle.

Dai YP, Bongalon S, Mutafova-Yambolieva VN, Yamboliev IA.

Adv Pharmacol Sci. 2008;2008:362741. doi: 10.1155/2008/362741. Epub 2007 Nov 6.

11.

New insights into mechanism and regulation of actin capping protein.

Cooper JA, Sept D.

Int Rev Cell Mol Biol. 2008;267:183-206. doi: 10.1016/S1937-6448(08)00604-7. Review.

12.

Structural basis and evolutionary origin of actin filament capping by twinfilin.

Paavilainen VO, Hellman M, Helfer E, Bovellan M, Annila A, Carlier MF, Permi P, Lappalainen P.

Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3113-8. Epub 2007 Feb 20.

13.
14.

Biological role and structural mechanism of twinfilin-capping protein interaction.

Falck S, Paavilainen VO, Wear MA, Grossmann JG, Cooper JA, Lappalainen P.

EMBO J. 2004 Aug 4;23(15):3010-9. Epub 2004 Jul 29.

16.

The two ADF-H domains of twinfilin play functionally distinct roles in interactions with actin monomers.

Ojala PJ, Paavilainen VO, Vartiainen MK, Tuma R, Weeds AG, Lappalainen P.

Mol Biol Cell. 2002 Nov;13(11):3811-21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk